MINI FUTURE LONG - MERCK & CO. | Market Closed - Börse Stuttgart 03:57:00 2024-06-26 pm EDT | ||
| 3.29 EUR | -2.37% |
|
| Current month | +25.10% | ||
| 1 month | +7.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 3.29 | -3.24% |
| 24-06-25 | 3.4 | +0.89% |
| 24-06-24 | 3.37 | +8.01% |
| 24-06-21 | 3.12 | +1.30% |
| 24-06-20 | 3.08 | +7.32% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 03:57 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD9LSN |
| ISIN | DE000MD9LSN3 |
| Date issued | 2022-10-20 |
| Strike | 96.76 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.84 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.47 € |
|---|---|
| Lowest since issue | 0.67 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5
USD
Average target price
142.7
USD
Spread / Average Target
+8.50%
- Stock Market
- Certificates
- Certificat
